2025-03-13: DEUSG Virtual

2025-03-13: DEUSG Virtual

Meeting Details

Date & Time: 13th March 2025, 11am UTC (Online)

Objectives

  • Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees:

 

Discussion items                                       

Description

Mins

Owner

Notes & Actions

Description

Mins

Owner

Notes & Actions

1

Opening

2

@Shane Byrnes 

Welcome & Notification of Recording

2

House Keeping

2

@Shane Byrnes 

@Alejandro Lopez Osornio 

Group Feedback on Alternating time zones proposal: (World Time Buddy)

  • March 13th: 11am UTC (online)

  • April 9th: 1.30pm CEST / 11.30am UTC (online & in person)

  • May: 10pm UTC (online)

  • June: 11am UTC (online)

  • July: 10pm UTC (online)

Meeting Notes:

  • Alternating timelines to be trialed in the months ahead.

3

Discussion Forum

2

@Shane Byrnes 

Discussion Forum has been set up.

  • To support community sharing of queries and updates between meetings.

  • Opportunity for community knowledge sharing on implementation. 

  • Use 'DEUSG' for Category.

  • Select 'Watch' on the Discussion Forum page to keep up to date.

Of Interest: SNOMED adding forum platform later this year ('Discourse')

Meeting Notes:

  • Nicki will post Patch strength briefing notes to the discussion forum to allow members to share further feedback. 

4

Current status of the Drug Model and proposals for modifications

30

@Matt Cordell / @Dion McMurtrie 

@Linda Bird  / @Guillermo Reynoso 

Continuation of Agenda Item from 20th Feb:

  • Australia Presentation

  • Follow on Information from Canada (use-cases)

  • Feedback to Irelands Proposal

    • How would approach manage salts in biosimilars or differences in SmPC documentation. 

  • Group Discussion/Comments on three proposals

Meeting Notes:

  • Group discussion Australia's and Canada's presentations: covering strength representation, subsumption of Clinical Drugs, and additional properties

 

5

Substances - Concepts in Extensions

5

@Alejandro Lopez Osornio

  • Work underway to collate list across extensions (MS and non-MS)

Meeting Notes:

  • Thanks to all members who submitted lists. 

6

Substances - authoring for medicines under evaluation (EMA)

2

@Shane Byrnes 

@Alejandro Lopez Osornio 

Meeting Notes:

  • No Update

7

Group discussion - Forum queries

10

All

Feedback on forum questions:

  • RxNorm - SNOMED Alignment

Meeting Notes:

  • Item deferred to April meeting

8

Oslo Preparation

2

@Shane Byrnes 

Seeking proposals for agenda items in Oslo

Meeting Notes:

  • Members to reach out to Alejandro and Shane to propose topics for April meetings

9

General Community Updates

2

@Alejandro Lopez Osornio @Shane Byrnes 

Open Briefing Note

Inactivation of Active Duplicate Descriptions in the Same Hierarchy

  • Relevant to Drug Modelling: basic dose form etc.

  • Link to Briefing Note on Confluence HERE

  • Feedback by 31st March 2025 to Maria Braithwaite via info@snomed.org

 

Expo 2025 - Call for Abstracts is Open

  • SNOMED CT Expo | SNOMED International

  • Call for abstracts is open until 24th April 2025

  • Outcome of submissions by 31st May 2025

  • Call open for Session Presentations, 10min Lightening Talks, or ePosters

10

AOB

2

 

 

  File Modified

PNG File image-2025-2-28_17-56-43.png

2025-Feb-28 by Shane Byrnes

PDF File DEUSG - AMTv4 – Why we deviated.pdf

2025-Mar-13 by Shane Byrnes

Copyright © 2025, SNOMED International